L ONG BEACH, Calif. -- Concomitant treatment with drugs for geographic atrophy (GA) and neovascular macular degeneration ...

Dr. Nimesh A. Patel reveals key findings on pegcetacoplan and anti-VEGF treatments for geographic atrophy and neovascular AMD ...

Geographic atrophy (GA) currently does not have a cure. However, therapeutic approaches such as complement system inhibition, gene therapy and cell-based therapies offer potential in slowing ...

Discussion of scientific information on unapproved uses (SIUU), off-label, investigational, or experimental drug/device use: ANX007, IONIS-FB-LRx, elamipretide, risuteganib, FHTR2163, GT005, and ...

4DMT Acquires Complement Pathway Inhibitor Payload for 4D-175 Product Candidate for Geographic Atrophy Apr. 24, 2023 8:00 AM ET 4D Molecular Therapeutics, Inc. (FDMT) ...

Anti-VEGF and anti-complement therapies work on distinct mechanisms in age-related macular degeneration, and both may be ...

Source Reference: Shen LL, et al "Determinants of four-year visual acuity loss in geographic atrophy -- An analysis of AREDS and AREDS2" Ophthalmology 2025; DOI: 10.1016/j.ophtha.2025.01.028.

By Shreoshree Chakrabarty: Geographic Atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that results in progressive and irreversible vision loss, particularly in older adults.

Last accessed: February 2025. 3 Colijn JM, Liefers B, Joachim N, et al. Enlargement of geographic atrophy from first diagnosis to end of life. JAMA Ophthalmol. 2021;139 (7):743–750.

Vakhaira added, "The biggest risk factor is family history. And so if anybody out there has a family member with geographic atrophy or macular degeneration, it is important to get annual eye exams." ...

Vakhaira added, "The biggest risk factor is family history. And so if anybody out there has a family member with geographic atrophy or macular degeneration, it is important to get annual eye exams." ...